Sign inJoin waitlistJoin the waitlist

Elizabeth Tower

Internal Medicine

Credentials: · · ·

History

Gastroenterology
University of Washington School of Medicine
2022–2025
Boston University
2022–2025
Doctor of Medicine
2018–2022

Research

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
Hepatology · 2015 · 390 citations
CTDSP1 inhibitor rabeprazole regulates DNA-PKcs dependent topoisomerase I degradation and irinotecan drug resistance in colorectal cancer
PLoS ONE · 2020 · 11 citations
Proteasome inhibitor, ixazomib prevents topoisomerase-I degradation and reverses irinotecan resistance in colorectal cancer
Molecular Oncology · 2026

AZ
Andrew Zhu
1 paper
Christopher Fan
1 paper
ES
Emma Swayze
1 paper
Tejaswini Reddy
1 paper